All In Biotech

Drug Trial Radar · NCT06575478

Evaluation of Fuling Yunhua Granules and Dihuang Baoyuan Granules in Drug Naive Type 2 Diabetes Patients

Evaluation of Fuling Yunhua Granules and Dihuang Baoyuan Granules in Type 2 Diabetes Patients With Poor Blood Glucose Control After Diet and Exercise Intervention: a Multi-center, Randomized, Double-blind, Placebo-controlled Clinical Study

Last checked: Nov 20, 2026Latest source record: Oct 5, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registry

Status

Completed

Enrollment

95

Actual

Start

Jul 31, 2024

Primary completion

Jan 27, 2025

Study completion Jan 27, 2025

Sponsor

Sponsor type
Industry
Collaborators
Peking University People's Hospital
First posted
Aug 28, 2024

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
Double (participant, investigator)
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
All sexes, from 18 years, up to 75 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The goal of this investigator-initiated clinical trial is to investigate the efficacy and safety of sequential therapy of Fuling Yunhua Granules (prescription A) and Dihuang Baoyuan Granule (prescription B) in the treatment of type 2 diabetes patients with poor glycemic control after diet and exercise intervention.

Conditions

  • Diabetes Mellitus, Type 2
  • Diabetes
  • Type2diabetes

Interventions

  • Fuling Yunhua GranulesDrug

    Fuling Yunhua Granules

  • Dihuang Baoyuan GranulesDrug

    Dihuang Baoyuan Granules

  • Fuling Yunhua Granules matched placebo/Dihuang Baoyuan Granules matched placeboDrug

    Fuling Yunhua Granules placebo/Dihuang Baoyuan Granules placebo

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Change in HbA1c Concentrations (%) From BaselineTime frame: 12 weeks

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Peking University People's Hospital

    Beijing, China

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.